Latest stories on BNTX
Moderna Tumbles 7% as Cancer Vaccine Selloff Deepens; BioNTech Falls 3%, Pfizer Holds Steady
24/7 Wall St.38 · neutralearnings
BioNTech and Bristol Myers Squibb Post Strong Phase 2 Pumitamig Data in Second‑Line Lung Cancer
TipRanks74 · bullishproduct/pr
BioNTech, DualityBiologics report DYNASTY-Breast02 met primary endpoint
The Fly74 · bullishproduct/pr
BioNTech, Bristol Myers announces data from Phase 2 ROSETTA Lung-107 trial
The Fly58 · neutralproduct/pr
Moderna (MRNA) vs. BioNTech (BNTX): Which Biotech Stock Offers Upside, According to Wall Street?
TipRanks58 · neutralanalyst
BioNTech to investigate pumitamig in combination with Gilead's Trodelvy
Seeking Alpha64 · neutralproduct/pr
Moderna Tumbles 25% After Apparent Early Leak of Melanoma Vaccine Data; BioNTech Dips, Pfizer Edges Higher
24/7 Wall St.38 · neutralproduct/pr
BioNTech and Gilead Recast Phase 3 ROSETTA Trial Around ADC Combo in Triple-Negative Breast Cancer
TipRanks63 · neutralproduct/pr
BioNTech announces collaboration, supply agreement with Gilead
The Fly64 · neutralproduct/pr
BioNTech to Report Third Quarter 2026 Financial Results and Corporate Update on November 3, 2026
GlobeNewswire50 · neutralgeneral
BioNTech to Report Third Quarter 2026 Financial Results and Corporate Update on November 3, 2026
Business Insider50 · neutralgeneral
BioNTech Showcases Broad Late-Stage Oncology Data and Novel Combinations at ESMO 2026
TipRanks62 · neutralproduct/pr
BioNTech to Showcase Oncology Late-Stage Pipeline Progress and Pumitamig Novel-Novel Combination Data at ESMO 2026
Business Insider63 · neutralproduct/pr
Another BioNTech Cancer Vaccine Just Hit a Major Setback. Is BNTX Stock Still a Buy?
The Motley Fool38 · neutralgeneral
Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline
The Motley Fool64 · neutralanalyst
Moderna Tumbles 10% as Profit Taking Hits Cancer Vaccine Rally; BioNTech Eases, Pfizer Stays Put
24/7 Wall St.38 · neutralgeneral
Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher
24/7 Wall St.64 · neutralgeneral
BioNTech Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into BioNTech (BNTX)
PR Newswire34 · bearishgeneral
BioNTech price target lowered to $132 from $136 at Canaccord
The Fly38 · neutralanalyst
BNTX Stock Selloff Deepens Doubts: BMO Ties BNT113 Miss To Wider mRNA Cancer Vaccine Struggles
Stocktwits News34 · bearishanalyst